IRIS
CONTE, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.436
Totale 1.436
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.436
Totale 1.436
Salva come PNG Salva come JPEG
Città #
Genova 829
Rapallo 220
Genoa 205
Vado Ligure 169
Bordighera 13
Totale 1.436
Salva come PNG Salva come JPEG
Nome #
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 141
Management of young women with early breast cancer 123
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 116
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 107
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 97
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 95
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 89
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer 85
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 84
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 78
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 70
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 63
Update on the management of breast cancer during pregnancy 61
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 60
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence 55
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 49
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 41
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 35
null 27
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 17
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 13
Totale 1.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.609
article - articoli 6.609
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 61 67 52 46 57 29 15
2020/2021200 13 21 18 16 19 21 9 20 11 27 10 15
2021/2022224 19 5 12 26 9 17 12 43 27 20 5 29
2022/2023262 24 36 2 26 41 36 4 13 45 2 33 0
2023/2024159 4 16 3 26 10 20 19 9 5 12 11 24
2024/2025190 22 30 4 34 56 44 0 0 0 0 0 0
Totale 1.506